Healthcare Global Enterprises
HCGNSE

Healthcare Global Enterprises

₹699.002.70 (0.39%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
687.50
Today’s high
717.45
52 week low
513.30
52 week high
799.71
Open price
695.60
Previous close
696.30
Live volume
1,08,585
Lower circuit
557.05
Upper circuit
835.55

Fundamentals

Market Cap
₹10,386Cr
ROE
2.90%
P/E Ratio(TTM)
311.95
EPS(TTM)
2.23
P/B Ratio
7.80
Dividend Yield
0.00%
Industry P/E
68.00
Book Value
89.21
Debt to Equity
1.30
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹707
+6.29%
Profit (Cr)
₹16.46
+307.43%
-1000100400900
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+14%
3Y CAGR+17%
Profit growthValue
1Y (TTM)+175%
3Y CAGR+8%

About

Healthcare Global Enterprises Limited (HCG) is a leading provider of cancer care in India, operating a network of comprehensive cancer centers.;
Founded in
1998
NSE symbol
HCG

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹507.55
-0.25 (0.05%)
L
    H
    16,095.4286.937.95
    ₹1,413.60
    -29.20 (2.02%)
    L
      H
      14,609.8550.338.75
      ₹297.30
      -4.10 (1.36%)
      L
        H
        9,884.0852.626.4
        ₹996.60
        +29.20 (3.02%)
        L
          H
          9,302.0553.315.22
          Livesquawk
          HealthCare Global sets annual maintenance CapEx target at INR 100 crore. Long-term marketing spend projected at 2.5-2.6% of sales.
          Livesquawk
          HealthCare Global plans 65 beds in FY27, 520 in FY28-29, and 230 in FY30. 60% of expansion from brownfield projects for faster execution and lower CapEx.
          Livesquawk
          HealthCare Global's North Bangalore hospital aims for monthly breakeven this year. Utilization is targeted at 60-65% in 3-4 years, with losses reducing from Q1 peak.
          Livesquawk
          HCG targets EBITDA margins of 21-22% in 2 years, 25% in 4-5 years. Growth driven by payor mix, clinical tech investments, and maturing centers.
          2026
          6
          Aug
          Quarterly Result
          Release date
          19
          May
          Quarterly & Annual Result
          Release date

          2
          Mar
          Rights Entitlement
          Ex date
          1:17
          Ratio

          1 rights eligible for every 17 existing shares held
          Ratio1:17
          Offer price₹512.00
          Ex date2 Mar ‘26
          Record date2 Mar ‘26
          Announcement date24 Feb ‘26

          24
          Feb
          Rights Entitlement
          Announced
          1:17
          Ratio

          1 rights eligible for every 17 existing shares held
          Ratio1:17
          Offer price₹512.00
          Ex date2 Mar ‘26
          Record date2 Mar ‘26
          Announcement date24 Feb ‘26
          5
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          1
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks